Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Airway Infection

ClinicalTrials.gov ID: NCT00499720

Public ClinicalTrials.gov record NCT00499720. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 22, 2026, 1:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Expanded Access Program for Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Airway Infection Who Have Limited Treatment Options and Are at Risk for Disease Progression

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this program is to provide expanded access to aztreonam lysine for inhalation (AZLI) 75 mg prior to its commercial availability to patients with cystic fibrosis (CF) and chronic P. aeruginosa airway infection who have limited treatment options and are at risk for disease progression.

Study identification

NCT ID: NCT00499720
Recruitment status: Approved For Marketing
Study type: Expanded access
Phase: Not listed
Lead sponsor: Gilead Sciences; Industry
Enrollment: Not listed

Conditions and interventions

Conditions

Interventions

Aztreonam Lysine for Inhalation Drug

Drug

Eligibility (public fields only)

Age range: 6 Years and older
Sex: All
Healthy volunteers: Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Not listed
Primary completion: Not listed
Completion: Not listed
Last update posted: Aug 2, 2011

United States locations

U.S. sites: 64
U.S. states: 32
U.S. cities: 56

Facility	City	State	ZIP	Site status
Not listed	Birmingham	Alabama	35233	—
Not listed	Anchorage	Alaska	99508	—
Not listed	Phoenix	Arizona	85016	—
Not listed	Little Rock	Arkansas	72205	—
Not listed	Los Angeles	California	90027	—
Not listed	Sacramento	California	95819	—
Not listed	San Francisco	California	94115	—
Not listed	San Francisco	California	94143	—
Not listed	Denver	Colorado	80045	—
Not listed	Denver	Colorado	80206	—
Not listed	Hartford	Connecticut	06102	—
Not listed	Hartford	Connecticut	06106	—
Not listed	Ft, Meyers	Florida	33908	—
Not listed	Gainesville	Florida	32610	—
Not listed	Orlando	Florida	32803	—
Not listed	St. Petersburg	Florida	33701	—
Not listed	Tampa	Florida	33606	—
Not listed	Boise	Idaho	83712	—
Not listed	Chicago	Illinois	60302	—
Not listed	Chicago	Illinois	60614	—
Not listed	Maywood	Illinois	60153	—
Not listed	Des Moines	Iowa	50309	—
Not listed	Wichita	Kansas	67214	—
Not listed	New Orleans	Louisiana	70112	—
Not listed	Boston	Massachusetts	02111	—
Not listed	Boston	Massachusetts	02114	—
Not listed	Detroit	Michigan	48201	—
Not listed	Minneapolis	Minnesota	54404	—
Not listed	Minneapolis	Minnesota	55455	—
Not listed	Columbia	Missouri	65212	—
Not listed	Kansas City	Missouri	64108	—
Not listed	Great Falls	Montana	59405	—
Not listed	Las Vegas	Nevada	89107	—
Not listed	Long Branch	New Jersey	07740	—
Not listed	New Brunswick	New Jersey	08901	—
Not listed	Albuquerque	New Mexico	87131	—
Not listed	Albany	New York	12208-3479	—
Not listed	Buffalo	New York	14222	—
Not listed	New Hyde Park	New York	11040	—
Not listed	New York	New York	10011	—
Not listed	New York	New York	10032	—
Not listed	Syracuse	New York	13210	—
Not listed	Valhalla	New York	10595	—
Not listed	Chapel Hill	North Carolina	27599-7220	—
Not listed	Akron	Ohio	44308	—
Not listed	Cincinnati	Ohio	45229	—
Not listed	Cleveland	Ohio	44106	—
Not listed	Columbus	Ohio	43205	—
Not listed	Toledo	Ohio	43605	—
Not listed	Oklahoma City	Oklahoma	73104	—
Not listed	Hershey	Pennsylvania	17033	—
Not listed	Philadelphia	Pennsylvania	19104	—
Not listed	Philadelphia	Pennsylvania	19134	—
Not listed	Pittsburgh	Pennsylvania	15213	—
Not listed	Sioux Falls	South Dakota	57117	—
Not listed	Memphis	Tennessee	38103	—
Not listed	Dallas	Texas	75230	—
Not listed	Fort Worth	Texas	76104	—
Not listed	San Antonio	Texas	78212	—
Not listed	Salt Lake City	Utah	84132-4701	—
Not listed	Norfolk	Virginia	23507	—
Not listed	Portsmouth	Virginia	23708	—
Not listed	Richmond	Virginia	23219	—
Not listed	Seattle	Washington	98195	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00499720, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Aug 2, 2011 · Synced Oct 22, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00499720 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →